latest news in companies
Apple Faces High Stakes as Surging Memory Chip Costs Threaten Holiday Growth
Cupertino, Monday, 2 November 2026.
Despite projecting $113.35 billion in quarterly revenue, Apple faces mounting pressure as rising memory component costs threaten to squeeze profit margins on its newly launched iPhone Duo.
Continental Diamond Tool Expands Manufacturing Reach with Strategic Dual Deal
New Haven, Monday, 2 November 2026.
Continental Diamond Tool has acquired PG&F Superabrasives and partnered with Winterthur Technology Group, instantly becoming one of America’s largest precision tooling providers while integrating advanced 3D-printed manufacturing capabilities.
cbdMD Diversifies Beyond Hemp with Twinlab Acquisition
Charlotte, Monday, 2 November 2026.
Facing cannabis industry headwinds, cbdMD finalized its distressed asset takeover of legacy supplement maker Twinlab on November 2, absorbing $30 million in trailing revenue to enter mainstream retail channels.
SpaceX Stock Navigates Post-Public Volatility as Artificial Intelligence Drives Growth
New York, Monday, 2 November 2026.
Despite hovering below its June peak at a $1.83 trillion valuation, SpaceX’s emerging artificial intelligence segment generated $7.6 billion in third-quarter revenue, rapidly becoming its primary operational profit driver.
Why Apple's New Leader Faces a Critical Test as Component Prices Climb
Cupertino, Monday, 2 November 2026.
Surging memory prices threaten Apple’s profit margins, putting new chief executive John Ternus to his first major financial test just two months into managing the five-trillion-dollar tech giant.
How Predictive Software Is Leveling the Playing Field for Mid-Market Freight
Brussels, Monday, 2 November 2026.
MG Ship has launched an affordable predictive platform giving mid-sized European logistics operators access to enterprise-level forecasting tools, helping safeguard margins against trade volatility with rapid one-week deployment.
ChemExpress Secures Rare Flawless Score in First U.S. Health Regulator Audit
Ma’anshan, Monday, 2 November 2026.
ChemExpress achieved a rare, observation-free clearance during its initial U.S. FDA audit at its Ma’anshan plant, validating the facility’s manufacturing standards for American pharmaceutical supply chains.